V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003305 | 10002113 | 1.7 | null | Neo-adjuvant (N) | 2017-10-04 | 2017-10-25 | Fluorouracil + Folinic Acid Weekly | N | N | 10469050 | FLUOROURACIL |
| 10003306 | 10002114 | null | 65.5 | Adjuvant (A) | 2016-11-06 | 2016-11-08 | BCG Intravesical | null | N | 10469062 | CHOP |
| 10003307 | 10002114 | 1.74 | 90.1 | Adjuvant (A) | 2018-07-28 | 2018-08-04 | BCG Intravesical | N | N | 10469062 | EC |
| 10003308 | 10002115 | null | null | Curative (C) | 2013-04-29 | 2013-05-14 | Cisplatin + Radiotherapy | N | Y | 10469200 | CISPLATIN + RT |
| 10003309 | 10006395 | 1.77 | null | Curative (C) | 2016-11-19 | 2016-11-19 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10469222 | PACLITAXEL |
| 10003310 | 10002116 | 1.68 | null | Curative (C) | 2016-09-16 | 2016-09-25 | CHOP - 21 days | 02 | N | 10469225 | CISPLATIN |
| 10003311 | 10002117 | 1.66 | 83 | Palliative (P) | 2018-05-19 | 2018-05-29 | FLUOROURACIL | 02 | N | 10469231 | FLUOROURACIL |
| 10003312 | 10002117 | 1.65 | null | Disease modification (D) | 2018-11-12 | 2018-11-26 | CHOP - 21 days | N | N | 10469231 | CTD |
| 10003313 | 10002117 | null | 87.5 | Curative (C) | null | 2016-05-17 | Azacitidine | N | N | 10469231 | FLUOROURACIL + MITOMYCIN + RT |
| 10003314 | 10002117 | 1.58 | 61.6 | Curative (C) | 2015-08-08 | 2015-08-08 | Cisplatin 100 + RT(H&N) 1 day | N | null | 10469231 | CISPLATIN + RT |
| 10003315 | 10002118 | null | 96 | Adjuvant (A) | 2017-08-20 | 2017-08-22 | FEC 100 + DOCETAXEL | null | N | 10469325 | FEC + DOCETAXEL |
| 10003316 | 10002118 | 1.78 | 71.5 | Palliative (P) | 2016-08-05 | 2016-08-13 | Chlorambucil | 02 | N | 10469325 | ABVD |
| 10003317 | 10002119 | 1.61 | 78.9 | Palliative (P) | 2016-03-26 | 2016-03-31 | Gemcitabine + Capecitabine | N | N | 10469418 | CTD |
| 10003318 | 10002119 | 1.57 | 60.7 | Curative (C) | 2018-06-24 | 2018-07-10 | Gemcitabine + Capecitabine | 02 | N | 10469418 | CAPECITABINE + GEMCITABINE |
| 10003319 | 10002120 | 1.74 | 73.6 | Palliative (P) | 2016-07-21 | 2016-08-22 | Bortezomib +/- Dexamethasone | 02 | N | 10469501 | IMATINIB |
| 10003320 | 10002121 | 1.68 | 70.5 | Adjuvant (A) | 2015-04-28 | 2015-05-10 | Fluouracil continuous infusion | N | N | 10469545 | FLUOROURACIL |
| 10003321 | 10002121 | 1.78 | 1.47 | Neo-adjuvant (N) | 2016-10-05 | 2016-10-25 | Fluorouracil + Folinic Acid Weekly | null | Y | 10469545 | FLUOROURACIL |
| 10003322 | 10002122 | 1.51 | 72 | Curative (C) | 2016-04-06 | 2016-04-13 | Fluorouracil + Folinic Acid Weekly | 2 | N | 10469626 | FLUOROURACIL |
| 10003323 | 10002122 | 1.82 | null | Curative (C) | 2013-11-09 | 2013-11-10 | Chlorambucil | 02 | N | 10469626 | CISPLATIN |
| 10003324 | 10002122 | 1.61 | 74.8 | Adjuvant (A) | 2016-07-14 | 2016-07-28 | Fluorouracil + Folinic Acid Weekly | 2 | Y | 10469626 | FLUOROURACIL |
| 10003325 | 10002122 | null | 55.8 | Neo-adjuvant (N) | 2018-06-20 | 2018-06-20 | EC | Y | N | 10469626 | CAPECITABINE + GEMCITABINE |
| 10003326 | 10002123 | 1.76 | 111.2 | Palliative (P) | 2016-10-22 | 2016-11-03 | CHOP - 21 days | 02 | N | 10469811 | ABVD |
| 10003327 | 10002124 | 1.79 | 86 | Curative (C) | null | 2017-03-09 | ABVD | N | N | 10470085 | IMATINIB |
| 10003328 | 10002124 | 1.7 | 66.4 | Disease modification (D) | null | 2016-07-19 | Gemcitabine + Capecitabine | N | N | 10470085 | BORTEZOMIB |
| 10003329 | 10002124 | 1.77 | 117 | null | 2016-05-23 | 2016-06-14 | Chlorambucil | N | Y | 10470085 | CAPECITABINE + GEMCITABINE |
| 10003330 | 10002124 | 0 | null | Adjuvant (A) | 2018-10-03 | 2018-10-07 | FEC 60 OR 75 + DOCETAXEL | 2 | N | 10470085 | FEC + DOCETAXEL |
| 10003331 | 10002125 | null | 82.8 | Disease modification (D) | 2019-01-04 | 2019-01-04 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10470300 | BCG |
| 10003332 | 10002125 | 1.8 | 77 | Curative (C) | 2018-01-22 | 2018-02-12 | Temozolomide + RT | N | N | 10470300 | EC |
| 10003333 | 10008076 | 1.57 | 76.4 | Palliative (P) | 2016-11-15 | 2016-11-15 | CTD Attenuated (Thalidomide 50mg) | N | N | 10470340 | EC |
| 10003334 | 10002126 | 0 | 75.8 | Adjuvant (A) | 2017-04-01 | 2017-10-08 | ABVD | 02 | N | 10470368 | CHLORAMBUCIL |
| 10003335 | 10002127 | 1.82 | 0 | Adjuvant (A) | 2018-11-05 | 2018-11-23 | FEC 100 + DOCETAXEL | 02 | N | 10470473 | FEC + DOCETAXEL |
| 10003336 | 10002127 | 1.77 | 89 | null | 2016-01-02 | 2016-01-02 | Bortezomib + Cyclophos + Dex | N | Y | 10470473 | CISPLATIN |
| 10003337 | 10002128 | 1.5 | 65.4 | Palliative (P) | null | 2016-04-23 | Paclitaxel 7 day | N | N | 10470674 | CVD |
| 10003338 | 10002129 | 1.82 | 118 | Adjuvant (A) | 2017-09-19 | 2017-09-20 | FEC + DOCETAXEL | 02 | N | 10470727 | FEC + DOCETAXEL |
| 10003339 | 10006404 | 0 | 63 | Disease modification (D) | 2016-01-09 | 2016-01-09 | Bortezomib +/- Dexamethasone | 2 | N | 10470767 | BORTEZOMIB |
| 10003340 | 10006404 | 1.7 | 82.2 | null | 2017-11-16 | 2017-11-17 | Capecitabine + Cisplatin | N | N | 10470767 | TEMOZOLOMIDE + RT |
| 10003341 | 10006404 | 0 | 68.2 | Curative (C) | null | 2016-12-02 | Bortezomib + Cyclophos + Dex | N | N | 10470767 | CHOP |
| 10003342 | 10002130 | 1.7 | 0 | Adjuvant (A) | null | 2015-01-18 | Bortezomib + Cyclophos + Dex | N | N | 10471054 | BORTEZOMIB |
| 10003343 | 10002131 | 1.75 | 87.4 | Disease modification (D) | 2017-06-04 | 2017-07-13 | EC | 02 | Y | 10471073 | EC |
| 10003344 | 10002132 | null | null | Adjuvant (A) | 2016-05-24 | 2016-06-01 | EC | N | N | 10471337 | CHLORAMBUCIL |
| 10003345 | 10002132 | 1.66 | 122.7 | Curative (C) | 2017-07-04 | 2017-07-28 | Capecitabine 35days + RT | N | Y | 10471337 | CAPECITABINE + RT |
| 10003346 | 10002133 | 1.63 | 71.8 | Palliative (P) | 2016-09-24 | 2016-09-30 | FLUOROURACIL | N | N | 10471856 | FLUOROURACIL |
| 10003347 | 10002134 | 1.68 | 68.7 | Curative (C) | 2016-03-30 | 2016-03-30 | Imatinib 400mg | 02 | N | 10471931 | BORTEZOMIB |
| 10003348 | 10002135 | 1.68 | 55 | Curative (C) | 2015-09-11 | 2015-09-15 | CISPLATIN + RT | N | Y | 10472026 | CISPLATIN + RT |
| 10003349 | 10002136 | null | null | Curative (C) | 2017-06-19 | 2017-06-30 | CAPECITABINE + RT | 02 | Y | 10472173 | CAPECITABINE + RT |
| 10003350 | 10002137 | 1.56 | 50 | Disease modification (D) | 2016-03-09 | 2016-03-26 | Cisplatin + Etoposide (3 day) | 2 | Y | 10472245 | BORTEZOMIB |
| 10003351 | 10006406 | 1.7 | 68.4 | null | 2014-11-18 | 2015-04-21 | CAPECITABINE + RT | 2 | Y | 10472296 | CAPECITABINE + RT |
| 10003352 | 10002138 | 1.78 | 91.05 | Adjuvant (A) | 2018-06-08 | 2018-06-10 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10472325 | FLUOROURACIL + MITOMYCIN + RT |
| 10003353 | 10002138 | 0 | 0 | Curative (C) | 2016-05-03 | 2016-06-02 | CTD | N | Y | 10472325 | FLUOROURACIL + MITOMYCIN + RT |
| 10003354 | 10002138 | 1.67 | 65 | Palliative (P) | 2017-01-13 | 2017-01-13 | Irinotecan + Modified De Gramont | null | N | 10472325 | IRINOTECAN + MDG |